Literature DB >> 6352497

Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity.

E Carlson.   

Abstract

Nine Staphylococcus aureus strains isolated from patients with toxic shock syndrome (TSS), two strains from non-disease-associated sources, and four strains from disease (not TSS)-associated sources were characterized for the intraperitoneal dose necessary to kill 50% of exposed animals (LD50) and toxic shock toxin production and studied for synergistic effects on mouse mortality and morbidity when combined with a sublethal dose of Candida albicans and inoculated intraperitoneally. Representative toxic shock toxin-producing strains (free of other enterotoxins) exhibited the following unique set of characteristics when inoculated intraperitoneally into mice and compared with all other strains tested: (i) lowest virulence when inoculated alone into mice as determined by the LD50; (ii) greatest synergistic decrease in LD50 (up to 70,000-fold as compared to up to 200-fold for other strains) when combined with C. albicans and injected intraperitoneally; and (iii) induced a characteristic, dose-independent, temporal death pattern in dually injected animals. When sublethal dual doses were used, animals receiving disease (TSS and not TSS)-associated S. aureus in combination with C. albicans developed symptoms, but some differences in symptomatologies, depending on the strain, were observed. The symptoms included conjunctivitis; gastrointestinal, neurological, and circulatory abnormalities; rash followed by desquamation; and patchy baldness. Although overlap in symptoms between animal treatment groups was observed, certain symptoms (neurological sequeae and petechial hemorrhages) were observed only in animals inoculated with a specific S. aureus strain combined with C. albicans. Animals receiving sublethal dual doses, which included non-disease-associated S. aureus, did not develop symptoms. When Staphylococcus epidermidis was combined with C. albicans and inoculated into mice, no synergistic effects on morbidity or mortality were observed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352497      PMCID: PMC264556          DOI: 10.1128/iai.42.1.285-292.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  SPECIFIC AND NONSPECIFIC IMMUNITY IN CANDIDA INFECTIONS. EXPERIMENTAL STUDIES OF THE ROLE OF CANDIDA CELL CONSTITUENTS AND REVIEW OF LITERATURE.

Authors:  B DOBIAS
Journal:  Acta Med Scand       Date:  1964

2.  Estimation of LD50 by moving averages.

Authors:  B M BENNETT
Journal:  J Hyg (Lond)       Date:  1952-06

3.  Inveterate vaginal thrush.

Authors:  R Hurley
Journal:  Practitioner       Date:  1975-12

4.  Detecting the enterotoxigenicity of Staphylococcus aureus strains.

Authors:  R Robbins; S Gould; M Bergdoll
Journal:  Appl Microbiol       Date:  1974-12

5.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

6.  Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits.

Authors:  D F Scott; J M Kling; J J Kirkland; G K Best
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality.

Authors:  E Carlson
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Characterization of the hemolytic activity of Staphylococcus aureus strains associated with toxic shock syndrome.

Authors:  A W Chow; M J Gribble; K H Bartlett
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

9.  Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice.

Authors:  E Carlson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Clinical and laboratory manifestations of toxic shock syndrome.

Authors:  R W Tofte; D N Williams
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

View more
  38 in total

Review 1.  Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists.

Authors:  P Frey-Klett; P Burlinson; A Deveau; M Barret; M Tarkka; A Sarniguet
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

2.  Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance.

Authors:  Melphine M Harriott; Mairi C Noverr
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

Review 3.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

4.  Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages.

Authors:  D H Beezhold; G K Best; P F Bonventre; M Thompson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Single-cell force spectroscopy of the medically important Staphylococcus epidermidis-Candida albicans interaction.

Authors:  Audrey Beaussart; Philippe Herman; Sofiane El-Kirat-Chatel; Peter N Lipke; Soňa Kucharíková; Patrick Van Dijck; Yves F Dufrêne
Journal:  Nanoscale       Date:  2013-09-20       Impact factor: 7.790

6.  Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.

Authors:  Brian M Peters; Mairi C Noverr
Journal:  Infect Immun       Date:  2013-04-01       Impact factor: 3.441

7.  Systemic Staphylococcus aureus infection mediated by Candida albicans hyphal invasion of mucosal tissue.

Authors:  Lisa Marie Schlecht; Brian M Peters; Bastiaan P Krom; Jeffrey A Freiberg; Gertrud M Hänsch; Scott G Filler; Mary Ann Jabra-Rizk; Mark E Shirtliff
Journal:  Microbiology       Date:  2014-10-20       Impact factor: 2.777

Review 8.  Candida albicans interactions with bacteria in the context of human health and disease.

Authors:  Diana K Morales; Deborah A Hogan
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

9.  Microbial interactions and differential protein expression in Staphylococcus aureus -Candida albicans dual-species biofilms.

Authors:  Brian M Peters; Mary Ann Jabra-Rizk; Mark A Scheper; Jeff G Leid; John William Costerton; Mark E Shirtliff
Journal:  FEMS Immunol Med Microbiol       Date:  2010-06-07

10.  Protection by Candida albicans of Staphylococcus aureus in the establishment of dual infection in mice.

Authors:  E Carlson; G Johnson
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.